Key statistics
As of last trade Swedish Orphan Biovitrum AB (publ) (B6E:MUN) traded at 38.16, -2.60% below its 52-week high of 39.18, set on Feb 13, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 38.48 |
|---|---|
| High | 38.48 |
| Low | 38.16 |
| Bid | 37.94 |
| Offer | 37.98 |
| Previous close | 38.54 |
| Average volume | 452.43 |
|---|---|
| Shares outstanding | 357.41m |
| Free float | 197.59m |
| P/E (TTM) | 314.31 |
| Market cap | 145.68bn SEK |
| EPS (TTM) | 1.30 SEK |
Data delayed at least 15 minutes, as of Feb 16 2026 08:05 GMT.
More ▼
- Data presented at ACR Convergence 2025 highlight Sobi’s commitment to advancing care across rare and underserved inflammatory conditions
- Sobi Announces U.S. Food and Drug Administration Approves Doptelet® (avatrombopag) for the Treatment of Thrombocytopenia in Pediatric Patients One Year and Older with Persistent or Chronic Immune Thrombocytopenia (ITP)
